192 related articles for article (PubMed ID: 32795450)
41. Bioscavengers for the protection of humans against organophosphate toxicity.
Doctor BP; Saxena A
Chem Biol Interact; 2005 Dec; 157-158():167-71. PubMed ID: 16293236
[TBL] [Abstract][Full Text] [Related]
42. Monoclonal antibody AE-2 modulates carbamate and organophosphate inhibition of fetal bovine serum acetylcholinesterase.
Wolfe AD; Chiang PK; Doctor BP; Fryar N; Rhee JP; Saeed M
Mol Pharmacol; 1993 Dec; 44(6):1152-7. PubMed ID: 8264551
[TBL] [Abstract][Full Text] [Related]
43. Simulated dermal contamination with capillary samples and field cholinesterase biomonitoring.
Yuknavage KL; Fenske RA; Kalman DA; Keifer MC; Furlong CE
J Toxicol Environ Health; 1997 May; 51(1):35-55. PubMed ID: 9169060
[TBL] [Abstract][Full Text] [Related]
44. Characterization of monoclonal antibodies that inhibit the catalytic activity of acetylcholinesterases.
Gentry MK; Moorad DR; Hur RS; Saxena A; Ashani Y; Doctor BP
J Neurochem; 1995 Feb; 64(2):842-9. PubMed ID: 7830078
[TBL] [Abstract][Full Text] [Related]
45. Monoclonal antibodies against a C-terminal peptide of human brain acetylcholinesterase distinguish between erythrocyte and brain acetylcholinesterases.
Boschetti N; Brodbeck U; Jensen SP; Koch C; Nørgaard-Pedersen B
Clin Chem; 1996 Jan; 42(1):19-23. PubMed ID: 8565226
[TBL] [Abstract][Full Text] [Related]
46. Cross-homologies and structural differences between human cholinesterases revealed by antibodies against cDNA-produced human butyrylcholinesterase peptides.
Dreyfus P; Zevin-Sonkin D; Seidman S; Prody C; Zisling R; Zakut H; Soreq H
J Neurochem; 1988 Dec; 51(6):1858-67. PubMed ID: 2460589
[TBL] [Abstract][Full Text] [Related]
47. An inhibitor-free assay of acetylcholinesterase and butyrylcholinesterase in the cerebrospinal fluid.
Kluge HH; Kluge WH; Hartmann W
Clin Chim Acta; 1999 Apr; 282(1-2):135-45. PubMed ID: 10340441
[TBL] [Abstract][Full Text] [Related]
48. Characterization of cholinesterases in the damselfish Sergeant major (Abudefduf saxatilis).
Rodríguez-Fuentes G; Soto M; Luna-Ramírez K
Ecotoxicol Environ Saf; 2013 Oct; 96():99-102. PubMed ID: 23886799
[TBL] [Abstract][Full Text] [Related]
49. Use of cholinesterases as pretreatment drugs for the protection of rhesus monkeys against soman toxicity.
Wolfe AD; Blick DW; Murphy MR; Miller SA; Gentry MK; Hartgraves SL; Doctor BP
Toxicol Appl Pharmacol; 1992 Dec; 117(2):189-93. PubMed ID: 1471150
[TBL] [Abstract][Full Text] [Related]
50. Localization of butyrylcholinesterase at the neuromuscular junction of normal and acetylcholinesterase knockout mice.
Blondet B; Carpentier G; Ferry A; Chatonnet A; Courty J
J Histochem Cytochem; 2010 Dec; 58(12):1075-82. PubMed ID: 20805581
[TBL] [Abstract][Full Text] [Related]
51. Determination of cholinesterase in blood and tissue.
Wilson BW; Henderson JD
Curr Protoc Toxicol; 2007 Nov; Chapter 12():Unit12.13. PubMed ID: 23045138
[TBL] [Abstract][Full Text] [Related]
52. Acetylcholinesterase and butyrylcholinesterase expression in adult rabbit tissues and during development.
Jbilo O; L'Hermite Y; Talesa V; Toutant JP; Chatonnet A
Eur J Biochem; 1994 Oct; 225(1):115-24. PubMed ID: 7925428
[TBL] [Abstract][Full Text] [Related]
53. Alkaloids of Amaryllidaceae as Inhibitors of Cholinesterases (AChEs and BChEs): An Integrated Bioguided Study.
Cortes N; Sierra K; Alzate F; Osorio EH; Osorio E
Phytochem Anal; 2018 Mar; 29(2):217-227. PubMed ID: 29044771
[TBL] [Abstract][Full Text] [Related]
54. Reversible inhibition of acetylcholinesterase and butyrylcholinesterase by 4,4'-bipyridine and by a coumarin derivative.
Simeon-Rudolf V; Kovarik Z; Radić Z; Reiner E
Chem Biol Interact; 1999 May; 119-120():119-28. PubMed ID: 10421445
[TBL] [Abstract][Full Text] [Related]
55. Age-dependent changes in plasma and brain cholinesterase activities of house wrens and European starlings.
Mayack DT; Martin T
J Wildl Dis; 2003 Jul; 39(3):627-37. PubMed ID: 14567225
[TBL] [Abstract][Full Text] [Related]
56. Naturally Occurring Genetic Variants of Human Acetylcholinesterase and Butyrylcholinesterase and Their Potential Impact on the Risk of Toxicity from Cholinesterase Inhibitors.
Lockridge O; Norgren RB; Johnson RC; Blake TA
Chem Res Toxicol; 2016 Sep; 29(9):1381-92. PubMed ID: 27551784
[TBL] [Abstract][Full Text] [Related]
57. Amino acid residues involved in the interaction of acetylcholinesterase and butyrylcholinesterase with the carbamates Ro 02-0683 and bambuterol, and with terbutaline.
Kovarik Z; Radić Z; Grgas B; Skrinjarić-Spoljar M; Reiner E; Simeon-Rudolf V
Biochim Biophys Acta; 1999 Aug; 1433(1-2):261-71. PubMed ID: 10446376
[TBL] [Abstract][Full Text] [Related]
58. Cholinesterase Inhibitory Activity of Some semi-Rigid Spiro Heterocycles: POM Analyses and Crystalline Structure of Pharmacophore Site.
Hadda TB; Talhi O; Silva ASM; Senol FS; Orhan IE; Rauf A; Mabkhot YN; Bachari K; Warad I; Farghaly TA; Althagafi II; Mubarak MS
Mini Rev Med Chem; 2018; 18(8):711-716. PubMed ID: 28714400
[TBL] [Abstract][Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
